InSyGen is currently a privately held company. It was formed in 2008 to

discover human drug targets, develop and commercialise human therapeutics.

The initial fields are Obesity and Diabetes.

 

InSyGen is a unique initiative in major public health and economic issues of global significance.

 

ENQUIRIES: info@insygen.com